ARCHIVES

Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board

This article is from The Cancer Letter archive.

Vol. 15 No. 05 | February 3, 1989

Download PDF Visit The Full Archive

Related Articles

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

DCT Board Approves Drug Development Recompetition

November 30, 1990